- Home
- VINC
VINC
Vincerx Pharma Inc.
as 12-18-2024 12:44pm EST
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | PALO ALTO |
| Market Cap: | 6.2M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 564.7K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.18 - $9.37 | Next Earning Date: | 11-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Vincerx Pharma Inc. News
VINC Breaking Stock News: Dive into VINC Ticker-Specific Updates for Smart Investing
TipRanks
13 days ago
Vincerx Pharma announces workforce reduction of 55%, cost-control measures
GlobeNewswire
14 days ago
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943
GlobeNewswire
a month ago
Vincerx Pharma Reports Third Quarter 2024 Financial Results
Zacks
2 months ago
What Makes Vincerx Pharma (VINC) a New Buy Stock
MT Newswires
2 months ago
Vincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours
GlobeNewswire
2 months ago
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates
Simply Wall St.
4 months ago
Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky
GlobeNewswire
4 months ago
Vincerx Pharma Reports Second Quarter 2024 Financial Results
Compare VINC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VINC Vincerx Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.